Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site.
Goedken ER, Argiriadi MA, Dietrich JD, Petros AM, Krishnan N, Panchal SC, Qiu W, Wu H, Zhu H, Adams AM, Bodelle PM, Goguen L, Richardson PL, Slivka PF, Srikumaran M, Upadhyay AK, Wu B, Judge RA, Vasudevan A, Gopalakrishnan SM, Cox PB, Stoll VS, Sun C.
Goedken ER, et al. Among authors: krishnan n.
Sci Rep. 2022 Aug 26;12(1):14561. doi: 10.1038/s41598-022-18760-1.
Sci Rep. 2022.
PMID: 36028520
Free PMC article.